Call us today 212-583-0100

Press Releases

Please view the latest press from Enzo Biochem, Inc.

Date Details
Wednesday April 21, 2021 Enzo’s Universal AMPICOLLECT™ Used on GENFLEX® Molecular Platform Cleared for Distribution by FDA Under Emergency Use Authorization
Wednesday March 17, 2021 ENZO BIOCHEM TO PRESENT AT THE KEYBANC CAPITAL MARKETS' LIFE SCIENCES & MEDTECH INVESTOR FORUM
Monday March 15, 2021 Enzo Biochem Reports Second Quarter Fiscal 2021 Results; Company Provides Leadership and Corporate Updates
Thursday March 04, 2021 Enzo Biochem to Participate in the H.C. Wainwright Global Life Sciences Conference
Tuesday March 02, 2021 Enzo Announces its GENFLEX™ Molecular Test Detects Current COVID-19 Variants
Monday March 01, 2021 Enzo Biochem to Report Second Quarter 2021 Financial Results on Monday, March 15
Wednesday February 03, 2021 Enzo Announces Issuance of U.S. Patent for Polyclonal Antibodies Against Osteoporosis Drug Target Sclerostin
Wednesday January 20, 2021 ENZO BIOCHEM’S BOARD OF DIRECTORS FORMS NEW CORPORATE DEVELOPMENT AND PLANNING & SUCCESSION COMMITTEES
Tuesday January 05, 2021 ENZO BIOCHEM TO PARTICIPATE IN THE LIFESCI PARTNERS 10TH ANNUAL HEALTHCARE CORPORATE ACCESS EVENT
Monday January 04, 2021 ENZO BIOCHEM RECEIVES FDA EMERGENCY USE AUTHORIZATION FOR TESTING POOLED SAMPLES ON THREE PLATFORMS INCLUDING COMPANY’S GENFLEX™ PROPRIETARY SYSTEM FOR DETECTION OF CORONAVIRUS SARS-CoV-2

To view releases from previous years, select the year below that you would like to see. You may chose to view the latest news or reports dating back to 2003.